| Immune system | |||||
|---|---|---|---|---|---|
| Immune system / Immune system disorders and transplantation | |||||
| anakinra | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA685 |
|||
| Solution for injection | |||||
| Kineret (Swedish Orphan Biovitrum Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| antithymocyte immunoglobulin (rabbit) | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA481 |
|||
|
NICE does not recommend this medicine as initial treatment to prevent organ rejection
This medicine is not recommended by NICE as initial treatment to prevent organ rejection in chlidren, young people and adults having a kidney transplant. Homerton University Hospital Foundation Trust does not provide this specialist service |
|||||
| Solution for infusion | |||||
| Antithymocyte immunoglobulin (rabbit) (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder and solvent for solution for infusion | |||||
| Thymoglobulin (Sanofi) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| avacopan | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA825 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral capsule | |||||
| Tavneos (Vifor Fresenius Medical Care Renal Pharma UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| azathioprine | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral suspension | |||||
| Jayempi (Nova Laboratories Ltd) | |||||
| Oral tablet | |||||
| Azathioprine (Non-proprietary) | |||||
| Imuran (Aspen Pharma Trading Ltd) | |||||
| basiliximab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA481 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder and solvent for solution for injection | |||||
| Simulect (Novartis Pharmaceuticals UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| belatacept | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA481 |
|||
|
NICE does not recommend this medicine as initial treatment to prevent organ rejection
This medicine is not recommended by NICE as initial treatment to prevent organ rejection in chlidren, young people and adults having a kidney transplant. Homerton University Hospital Foundation Trust does not provide this specialist service |
|||||
| Powder for solution for infusion | |||||
| Nulojix (Bristol-Myers Squibb Pharmaceuticals Ltd) | |||||
| belimumab | Hospital only |
NICE TA752 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for injection | |||||
| Benlysta (GlaxoSmithKline UK Ltd) | |||||
| Powder for solution for infusion | |||||
| Benlysta (GlaxoSmithKline UK Ltd) | |||||
| belumosudil |
NICE TA949 |
||||
| Oral tablet | |||||
| Rezurock (Sanofi) | |||||
| budesonide |
NICE TA708 NICE TA937 |
||||
| Orodispersible tablet | |||||
| Jorveza (Dr. Falk Pharma UK Ltd) | |||||
| Modified-release tablet | |||||
| Cortiment (Ferring Pharmaceuticals Ltd) | |||||
| Modified-release capsule | |||||
| Budesonide (Non-proprietary) | |||||
| Kinpeygo (Genus Pharmaceuticals Holdings Ltd) | |||||
| Gastro-resistant capsule | |||||
| Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
| Gastro-resistant granules | |||||
| Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
| Inhalation powder | |||||
| Budelin Novolizer (Viatris UK Healthcare Ltd) | |||||
| Easyhaler (Orion Pharma (UK) Ltd) | |||||
| Pulmicort Turbohaler (AstraZeneca UK Ltd) | |||||
| Nebuliser liquid | |||||
| Budesonide (Non-proprietary) | |||||
| Pulmicort Respules (AstraZeneca UK Ltd) | |||||
| Enema | |||||
| Entocort (Tillotts Pharma UK Ltd) | |||||
| Spray | |||||
| Budesonide (Non-proprietary) | |||||
| Rectal foam | |||||
| Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
| canakinumab | Not approved for prescribing | ||||
| Solution for injection | |||||
| Ilaris (Novartis Pharmaceuticals UK Ltd) | |||||
| chloroquine | Hospital only | ||||
|
Prescribing of chloroquine for travelling purposes
Chloroquine for malaria prophylaxis should not be issued on an NHS prescription. Patients should be prescribed this on a private prescription for travelling purposes. |
|||||
| Oral solution | |||||
| Malarivon (Wallace Manufacturing Chemists Ltd) | Hospital only | ||||
| Oral tablet | |||||
| Avloclor (Alliance Pharmaceuticals Ltd) | |||||
| ciclosporin | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA369 |
|||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
| Oral solution | |||||
| Neoral (Novartis Pharmaceuticals UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
| Sandimmun (Novartis Pharmaceuticals UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
| Solution for infusion | |||||
| Sandimmun (Novartis Pharmaceuticals UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
| Eye drops | |||||
| Ikervis (Santen UK Ltd) | |||||
| Verkazia (Santen UK Ltd) | |||||
| Oral capsule | |||||
| Ciclosporin (Non-proprietary) | |||||
| Capimune (Viatris UK Healthcare Ltd) | |||||
| Capsorin (Morningside Healthcare Ltd) | |||||
| Deximune (Dexcel-Pharma Ltd) | |||||
| Neoral (Novartis Pharmaceuticals UK Ltd) | |||||
| Sandimmun (Novartis Pharmaceuticals UK Ltd) | |||||
| Vanquoral (Teva UK Ltd) | |||||
| eculizumab |
NICE HST1 |
||||
| Solution for infusion | |||||
| Bekemv (Amgen Ltd) | |||||
| Epysqli (Samsung Bioepis NL B.V. Ltd) | |||||
| Soliris (Alexion Pharma UK Ltd) | |||||
| everolimus | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA421 NICE TA432 NICE TA449 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
NICE does not recommend this medicine as initial treatment to prevent organ rejection
This medicine is not recommended by NICE as initial treatment to prevent organ rejection in chlidren, young people and adults having a kidney transplant. Homerton University Hospital Foundation Trust does not provide this specialist service |
|||||
|
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
| Dispersible tablet | |||||
| Votubia (Novartis Pharmaceuticals UK Ltd) | |||||
| Oral tablet | |||||
| Everolimus (Non-proprietary) | |||||
| Afinitor (Novartis Pharmaceuticals UK Ltd) | |||||
| Certican (Novartis Pharmaceuticals UK Ltd) | |||||
| Votubia (Novartis Pharmaceuticals UK Ltd) | |||||
| hydroxychloroquine sulfate | Shared care guideline | ||||
|
HYDROXYCHLOROQUINE SULFATE
A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including prescribing. Click here to access the Shared Care Guideline for hydroxychloroquine
|
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral tablet | |||||
| Hydroxychloroquine sulfate (Non-proprietary) | |||||
| Quinoric (Bristol Laboratories Ltd) | |||||
| mycophenolate mofetil | Shared care guideline |
NICE TA481 NICE TA481 |
|||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Gastro-resistant tablet | |||||
| Mycophenolate mofetil (Non-proprietary) | Shared care guideline | ||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Ceptava (Sandoz Ltd) | |||||
| Myfortic (Novartis Pharmaceuticals UK Ltd) | Shared care guideline | ||||
|
This is not the same as mycophenolate mofetil
Please note this is a different salt of mycophenolate and is not interchangeable with mycophenolate mofetil. Please prescribe by brand. |
|||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral suspension | |||||
| Mycophenolate mofetil (Non-proprietary) | |||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| CellCept (Roche Products Ltd) | Shared care guideline | ||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Powder for solution for infusion | |||||
| CellCept (Roche Products Ltd) | |||||
| Oral tablet | |||||
| Mycophenolate mofetil (Non-proprietary) | |||||
| CellCept (Roche Products Ltd) | |||||
| Myfenax (Teva UK Ltd) | |||||
| Oral capsule | |||||
| Mycophenolate mofetil (Non-proprietary) | |||||
| CellCept (Roche Products Ltd) | |||||
| Myfenax (Teva UK Ltd) | |||||
| rituximab | Hospital only |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
|
Biosimilar
Truxima is the preferred biosimilar brand of rituximab for non-malignancy indications |
|||||
| Solution for injection | |||||
| MabThera (Roche Products Ltd) | |||||
| Solution for infusion | |||||
| MabThera (Roche Products Ltd) | Hospital only | ||||
| Rixathon (Sandoz Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Ruxience (Pfizer Ltd) | |||||
| Truxima (Celltrion Healthcare UK Ltd) | Hospital only | ||||
|
Biosimilar
Truxima is the preferred biosimilar brand of rituximab for non-malignancy indications |
|||||
| satralizumab | |||||
| Solution for injection | |||||
| Enspryng (Roche Products Ltd) | |||||
| sirolimus | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA481 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
NICE does not recommend this medicine as initial treatment to prevent organ rejection
This medicine is not recommended by NICE as initial treatment to prevent organ rejection in chlidren, young people and adults having a kidney transplant. Homerton University Hospital Foundation Trust does not provide this specialist service |
|||||
| Oral solution | |||||
| Rapamune (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Oral tablet | |||||
| Rapamune (Pfizer Ltd) | |||||
| tacrolimus | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA82 NICE TA481 NICE TA481 |
|||
|
Hospital only prescribing
Oral preparations of tacrolimus would generally be assigned 'hospital only prescribing' formulary status, unless an exceptional individual agreement exists between the GP and the specialist centre. |
|||||
|
Medicines for kidney transplant in children, young people and adults
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
| Modified-release tablet | |||||
| Envarsus (Chiesi Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
NICE does not recommend this medicine as initial treatment to prevent organ rejection
This medicine is not recommended by NICE as initial treatment to prevent organ rejection in chlidren, young people and adults having a kidney transplant. Homerton University Hospital Foundation Trust does not provide this specialist service |
|||||
| Modified-release capsule | |||||
| Advagraf (Astellas Pharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
NICE does not recommend this medicine as initial treatment to prevent organ rejection
This medicine is not recommended by NICE as initial treatment to prevent organ rejection in chlidren, young people and adults having a kidney transplant. Homerton University Hospital Foundation Trust does not provide this specialist service |
|||||
| Dailiport (Sandoz Ltd) | |||||
| Granules for oral suspension | |||||
| Modigraf (Astellas Pharma Ltd) | |||||
| Solution for infusion | |||||
| Prograf (Astellas Pharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Cutaneous ointment | |||||
| Tacrolimus (Non-proprietary) | |||||
| Protopic (LEO Pharma) | |||||
| Oral capsule | |||||
| Adoport (Sandoz Ltd) | |||||
| Prograf (Astellas Pharma Ltd) | |||||
| tocilizumab |
NICE TA375 NICE TA247 NICE TA518 NICE TA878 |
||||
| Solution for injection | |||||
| RoActemra (Roche Products Ltd) | |||||
| Tyenne (Fresenius Kabi Ltd) | |||||
| Solution for infusion | |||||
| RoActemra (Roche Products Ltd) | |||||
| Tyenne (Fresenius Kabi Ltd) | |||||
| voclosporin | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA882 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral capsule | |||||
| Lupkynis (Otsuka Pharmaceuticals (U.K.) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Immune system / Multiple sclerosis | |||||
| alemtuzumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA312 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Lemtrada (Sanofi) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cladribine | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA616 |
|||
| Solution for injection | |||||
| Litak (Lipomed GmbH) | |||||
| Solution for infusion | |||||
| Leustat (Atnahs Pharma UK Ltd) | |||||
| Oral tablet | |||||
| Mavenclad (Merck Serono Ltd) | |||||
| dimethyl fumarate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Plaque psoriasis
The Joint Formulary Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
|
Multiple slerosis
The Joint Prescribing Group (JPG) agreed NOT to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
|
Skilarence® NICE TA475 Tecfidera® NICE TA320 |
|||||
| Gastro-resistant tablet | |||||
| Skilarence (Almirall Ltd) | |||||
| Gastro-resistant capsule | |||||
| Dimethyl fumarate (Non-proprietary) | |||||
| Tecfidera (Biogen Idec Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| diroximel fumarate |
NICE TA794 |
||||
| Gastro-resistant capsule | |||||
| Vumerity (Biogen Idec Ltd) | |||||
| fampridine | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Modified-release tablet | |||||
| Fampyra (Biogen Idec Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| fingolimod | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA254 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral capsule | |||||
| Fingolimod (Non-proprietary) | |||||
| Gilenya (Novartis Pharmaceuticals UK Ltd) | |||||
| glatiramer acetate | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA527 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Brabio (Viatris UK Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Copaxone (Teva UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| interferon beta | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA527 NICE TA527 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Avonex (Biogen Idec Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Rebif (Merck Serono Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder and solvent for solution for injection | |||||
| Betaferon (Bayer Plc) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Extavia (Novartis Pharmaceuticals UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| natalizumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA127 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Tyruko (Sandoz Ltd) | |||||
| Tysabri (Biogen Idec Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ocrelizumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA533 NICE TA585 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Ocrevus (Roche Products Ltd) | |||||
| ofatumumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA699 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Kesimpta Sensoready (Novartis Pharmaceuticals UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ozanimod | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA706 NICE TA828 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral capsule | |||||
| Zeposia (Bristol-Myers Squibb Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| peginterferon beta-1a | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA624 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Plegridy (Biogen Idec Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ponesimod | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA767 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral tablet | |||||
| Ponvory (Janssen-Cilag Ltd) | |||||
| siponimod | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA656 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral tablet | |||||
| Mayzent (Novartis Pharmaceuticals UK Ltd) | |||||
| teriflunomide | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA303 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral tablet | |||||
| Teriflunomide (Non-proprietary) | |||||
| Aubagio (Sanofi) | |||||
| Immune system / Autoimmune hepatitis | |||||
| penicillamine | Hospital only | ||||
| Oral tablet | |||||
| Penicillamine (Non-proprietary) | |||||